TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
BTB Pharma AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
|
34
|
0 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
6
|
27
|
-7 |
EBITDA |
-5
|
27
|
-7 |
Total assets |
36
|
32
|
30 |
Current assets |
2
|
8
|
4 |
Current liabilities |
3
|
4
|
25 |
Equity capital |
33
|
28
|
5 |
- share capital |
5
|
4
|
5 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
91.7%
|
87.5%
|
16.7% |
Turnover per employee |
0
|
34
|
0 |
Profit as a percentage of turnover | 79.4% | ||
Return on assets (ROA) |
16.7%
|
84.4%
|
-23.3% |
Current ratio |
66.7%
|
200%
|
16.0% |
Return on equity (ROE) |
18.2%
|
96.4%
|
-140.0% |
Change turnover |
-34
|
34
|
0 |
Change turnover % | -100% | ||
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.